Anti-HER2 conjugated gold nanostructures enable photothermal tumor ablation, while iron oxide nanoparticles conjugated with anti-VEGF or CD105 antibodies support MRI-guided therapy and targeted cytotoxicity in HER2-positive cancers [136,137,138,139,140]. The gene discussed is ERBB2; the disease is cancer.